Youssef El Mouali

Youssef El Mouali

Auto-generated profile, based on publicly available information

Youssef El Mouali

Department of Microbial Immune Regulation, Helmholtz Centre for Infection Research, Braunschweig, Germany

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2021 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
YMYoussef El Mouali
Youssef El Mouali
MGMilan Gerovac
Milan Gerovac
RMRaminta Mineikaitė
Raminta Mineikaitė
JVJörg Vogel
Jörg Vogel
FinO-domain proteins represent an emerging family of RNA-binding proteins (RBPs) with diverse roles in bacterial post-transcriptional control and physiology. They exhibit an intriguing targeting spectrum, ranging from an assumed single RNA pair (FinP/traJ) for the plasmid-encoded FinO protein, to transcriptome-wide activity as documented for chromosomally encoded ProQ proteins. Thus, the shared FinO domain might bear an unusual plasticity enabling it to act either selectively or promiscuously on the same cellular RNA pool. One caveat to this model is that the full suite of in vivo targets of the assumedly highly selective FinO protein is unknown. Here, we have extensively profiled cellular transcripts associated with the virulence plasmid-encoded FinO in Salmonella enterica. While our analysis confirms the FinP sRNA of plasmid pSLT as the primary FinO target, we identify a second major ligand: the RepX sRNA of the unrelated antibiotic resistance plasmid pRSF1010. FinP and RepX are strikingly similar in length and structure, but not in primary sequence, and so may provide clues to understanding the high selectivity of FinO-RNA interactions. Moreover, we observe that the FinO RBP encoded on the Salmonella virulence plasmid controls the replication of a cohabitating antibiotic resistance plasmid, suggesting cross-regulation of plasmids on the RNA level.

17 August 2018 in Current Genetics
Verified
Journal Article
Closed access
PDF file
YMYoussef El Mouali
Youssef El Mouali
CBCarlos Balsalobre
Carlos Balsalobre

2 October 2026 in Nature Microbiology
Verified
Journal Article
Open access
PDF file
CTCaroline Tawk
Caroline Tawk
YMYoussef El Mouali
Youssef El Mouali
KHKun D. Huang
Kun D. Huang
SVSebastiaan Valkiers
Sebastiaan Valkiers
VHVitor Heidrich
Vitor Heidrich
TSTill Strowig
Till Strowig
Healthy human gut microbiota is dominated by Bacteroidaceae in industrialized populations and by Prevotellaceae in those with traditional lifestyles, but diet alone is insufficient to explain this dominance of different Bacteroidota. Here we screened 94 dietary components in synthetic gut communities and find that these two bacterial families compete for overlapping nutritional niches. Segatella copri , a key member of Prevotellaceae-rich communities, outcompeted Bacteroidaceae when preferred polysaccharides such as arabinan were available, but this advantage depended on community composition, particularly the presence of Enterobacteriaceae. Metatranscriptomics and targeted metabolomics further revealed that Enterobacteriaceae synergized with dietary components to promote Segatella dominance in human and mouse gut communities. These interactions were validated by using multiple E. coli and Segatella isolates. Analyses of global metagenomes also showed a positive correlation between Segatella -rich non-industrialized microbiomes and Enterobacteriaceae abundance. Our results establish an ecosystem-level dynamic interplay between dietary components and key gut commensals that favour the dominance of Prevotellaceae.

18 April 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
VCValentina Cosi
Valentina Cosi
VLVincent Lau
Vincent Lau
PKPetia Kovatcheva-Datchary
Petia Kovatcheva-Datchary
YMYoussef el Mouali
Youssef el Mouali
TWToby Wilkinson
Toby Wilkinson
JVJoerg Vogel
Joerg Vogel
The Prevotellaceae family comprises abundant, taxonomically diverse bacteria of the human microbiota that exhibit remarkable intraspecies variability and distinct phenotypes during host-microbe interactions. Yet functional investigations are hampered by the limited genetic tractability of this medically important bacterial family, rendering it understudied. Here, we apply antisense oligomer (ASO) technology to selectively inhibit translation of single or multiple mRNAs across nine Prevotellaceae species. Using ftsZ - and mreB -related phenotypes as morphogenic readouts, we demonstrate that ASOs can function as a tunable system to study essential gene function. Further, we show that ASOs can selectively deplete target species from a synthetic Bacteroidales community. These results establish ASOs as practical tools for functional genomics and community modulation in otherwise genetically intractable anaerobic microbiota members.